Al-qershi, Osamah
Nguyen, Tuong L.
Elliott, Michael S.
Schmidt, Daniel F.
Makalic, Enes
Li, Shuai
Fox, Samantha K.
Dowty, James G.
Peña-Solorzano, Carlos A.
Kwok, Chun Fung
Chen, Yuanhong
Wang, Chong
Lippey, Jocelyn
Brotchie, Peter
Carneiro, Gustavo
McCarthy, Davis J.
Jeong, Yeojin
Sung, Joohon
Frazer, Helen M. L.
Hopper, John L.
Funding for this research was provided by:
Cancer Council Victoria grant (AF7305)
Victoria Cancer Agency Early Career grant (ECRF19020)
NHMRC Emerging Leadership Fellowship (GNT2017373)
ARC Future Fellowship grant (FT190100525)
UK Research and Innovation grant (EP/Y018036/1)
National Institute for Health and Care Research grant (NIHR158213)
National Research Foundation, Korea (2020R1A2C2101041)
Australian government Medical Research Future Fund (MRFAI000090)
Ramaciotti Foundation and the National Breast Cancer Foundation (IIRS-20-054; IIRS-2024-0100)
Cancer Australia (2012799)
National Health and Medical Research Council (APP2006899)
University of Melbourne Dame Kate Campbell Distinguished Professorial Fellowship
NHMRC Fellowship grant (GMT1137349)
Article History
Received: 16 September 2025
Accepted: 25 May 2026
First Online: 28 May 2026
Declarations
Ethics approval and consent to participate: This study was approved by the ethics committee of the University of Melbourne under Ethics ID: 14545 and titled “Transforming Breast Cancer Screening with Artificial Intelligence (AI): An Exemplar for Broad AI Deployment in Healthcare.” Informed consent was waived by the board due to the data-only nature of the study.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.